- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04985097
Home-based Visual Training in Patients Implanted With Trifocal Diffractive Intraocular Lenses (OPTicTRAIN)
July 31, 2021 updated by: Increase-Tech
Preliminary Evaluation of the Clinical Benefit of a Novel Visual Rehabilitation System in Patients Implanted With Trifocal Diffractive Intraocular Lenses: A Blinded Randomized Placebo-controlled Clinical Trial
This multicentre randomised controlled trial aimed to reduce the visual discomfort that patients implanted with trifocal diffractive intraocular lenses may experience after surgery.
To this end, a visual training software (Optictrain) was developed in which Gabor patches were presented to the patient on a hand-held electronic device.
Patients who met all inclusion criteria and consented to participate underwent half an hour of visual training per day for a period of 20 consecutive days remotely on a colourimetrically characterised Samsung Galaxy Tab A device on which the Optictrain software (n=30) or a placebo software (n=30), respectively, was pre-installed.
Corrected and uncorrected near, intermediate and distance visual acuity (VA) and mesopic near and distance contrast sensitivity (CS) were measured monocularly and binocularly at two visits: during the first postoperative week (V0) and after 20 days of visual training with the assigned software (V1).
The statistical analysis of the results obtained in the study has not yet been carried out.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Valladolid, Spain, 47005
- Faculty of Medicine, University of Valladolid
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 18 an 90 years
- Patients implanted with trifocal diffractive intraocular lenses
- Availability and motivation to perform the visual training assigned
Exclusion Criteria:
- Age under 18 or over 90 years
- Presence of irregular cornea, illiteracy or cognitive impairment
- History of eye surgery or presence of any active ocular disease
- Intraoperative complications leading to significant visual sequelae
- Patients implanted with monofocal, extended depth of focus or refractive multifocal IOLs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Experimental group
Half an hour of active visual training per day for a period of 20 consecutive days with the Optictrain software
|
Postsurgical monocular and binocular assessment of corrected and uncorrected near, intermediate and distance visual acuity and near and distance mesopic contrast sensitivity before and after the assigned vision training
|
SHAM_COMPARATOR: Control group
Half an hour of using a videogame without specific stimuli to improve visual performance (Fun Kid Racing 3.53 for Android) per day for a period of 20 consecutive days
|
Postsurgical monocular and binocular assessment of corrected and uncorrected near, intermediate and distance visual acuity and near and distance mesopic contrast sensitivity before and after the assigned vision training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual acuity
Time Frame: During the first post-operative week and after 20 days of vision training with the randomly assigned software
|
Monocular and binocular corrected and uncorrected visual acuity under near, intermediate and distance conditions
|
During the first post-operative week and after 20 days of vision training with the randomly assigned software
|
Contrast sensitivity
Time Frame: During the first post-operative week and after 20 days of vision training with the randomly assigned software
|
Monocular and binocular mesopic contrast sensitivity under near and distance conditions
|
During the first post-operative week and after 20 days of vision training with the randomly assigned software
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2018
Primary Completion (ACTUAL)
June 30, 2021
Study Completion (ACTUAL)
July 20, 2021
Study Registration Dates
First Submitted
July 26, 2021
First Submitted That Met QC Criteria
July 26, 2021
First Posted (ACTUAL)
August 2, 2021
Study Record Updates
Last Update Posted (ACTUAL)
August 6, 2021
Last Update Submitted That Met QC Criteria
July 31, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASVENM-20-437
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Acuity Reduced Transiently
-
Indonesia UniversityCompletedVisual Acuity Reduced TransientlyIndonesia
-
University of TorontoKensington Eye InstituteTerminatedCataracts | Visual Acuity Reduced Transiently | Loss of Visual Contrast Sensitivity | Functional Visual LossCanada
-
Batman Training and Research HospitalCompletedMacula Edema | Menopause Surgical | Visual Acuity Reduced TransientlyTurkey
-
Edward J. HollandAlcon Research; Sirion Therapeutics, Inc.; Parsons Medical CommunicationsCompletedCorneal Edema | Cataracts | Visual Acuity Reduced Transiently | Retinal Structural Change, Deposit and DegenerationUnited States
-
Prof. Dr. Antonia M. JoussenCharite University, Berlin, GermanyTerminatedMacular Edema, Cystoid | Visual Acuity Reduced TransientlyGermany
-
Alcon ResearchQueensland University of TechnologyRecruiting
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchCompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
Clinical Trials on Implantation of trifocal diffractive intraocular lenses
-
Alexandria UniversityCompletedRefractive ErrorsEgypt
-
Bausch & Lomb IncorporatedCompleted
-
Weill Medical College of Cornell UniversityAlcon ResearchCompleted
-
University of Sao PauloCompletedLens Implantation, IntraocularBrazil
-
Medical University of ViennaCompletedPosterior Capsule Opacification
-
PD Dr. med. Eckart BertelmannCompleted
-
Charite University, Berlin, GermanyCompleted
-
Eye & ENT Hospital of Fudan UniversityUnknownCataract | PresbyopiaChina
-
PD Dr. med. Eckart BertelmannCompleted
-
Medical University of ViennaCompletedCataract | AstigmatismAustria